News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Joins NHIA Future of Infusion Advisory Council
For Melinta, membership in the FIAC provides the opportunity for critical collaboration with the association and other organizations serving patients requiring infusion therapies. This work helps to enhance continuity of care as patients transition out of the hospital.
Melinta Therapeutics Announces Expanded Reimbursement and Access for REZZAYO™ (rezafungin for injection)
October 2, 2023Press Release REZZAYO receives product-specific J-Code and is granted NTAP PARSIPPANY, N.J., October 2, 2023 – Melinta Therapeutics (Melinta), a commercial-stage company providing
MELINTA THERAPEUTICS ANNOUNCES COMMERCIAL AVAILABILITY OF REZZAYO™ (rezafungin for injection)
July 31, 2023 Press Release New Treatment for Candidemia and Invasive Candidiasis Now Available in the U.S PARSIPPANY, NJ, July 31, 2023 –Melinta Therapeutics, LLC today announced the availability
Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics for Use in Pediatric Patients, and for Use Against Biothreat Pathogens
July 10, 2023 Press Release Parsippany, NJ – Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today